507
Participants
Start Date
October 31, 2011
Primary Completion Date
December 31, 2012
Study Completion Date
January 31, 2013
Azilsartan medoxomil/placebo
Azilsartan medoxomil and placebo to chlorthalidone combination tablets
Azilsartan medoxomil - chlorthalidone
Azilsartan medoxomil and chlorthalidone fixed dose combination tablets
Haskovo
Pazardzhik
Pleven
Plovdiv
Sofia
Varna
Veliko Tarnovo
Paide
Saku
Tallinn
Tartu
Võru
Labarthe-sur-Lèze
Bourg-des-Comptes
Tours
Vourey
Saint-Étienne-de-Montluc
Orthez
Karlsruhe
Bad Wörishofen
Nuremberg
Hamburg
Frankfurt am Main
Stuhr
Essen
Kamp-Lintfort
Mainz
Dresden
Budapest
Debrecen
Gyöngyös
Gyula
Mosonmagyaróvár
Nyíregyháza
Pécs
Szikszó
Torrette Di Ancona
Acquaviva delle Fonti
Brescia
Ferrara
L’Aquila
Milan
Palermo
Pavia
Pisa
Roma
Sassari
Legnago
Bologna
Alytus
Kaunas
Beek
Breda
Eindhoven
Groningen
Leiderdorp
Maastricht
Rotterdam
Velp
Zoetermeer
Zwijndrecht
Bydgoszcz
Gdansk
Gdynia
Krakow
Lodz
Lublin
Oświęcim
Parczew
Poznan
Pulway
Rzeszów
Sopot
Torun
Zgierz
Belgrade
Kamenitz
Kragujevac
Kruševac
Niš
Zemun
Bardejov
Bratislava
Galanta
Komárno
Košice
Lučenec
Martin
Nitra
Nové Zámky
Prešov
Svidník
Žilina
Barcelona
Centelles
Madrid
Málaga
Gothenburg
Lund
Malmo
Vällingby
London
Glasgow
Blackpool
Northwood
Bath
Royal Leamington Spa
Westbury
Lead Sponsor
Takeda
INDUSTRY